Navigation Links
Uroplasty To Participate In Two Upcoming Conferences
Date:8/8/2012

MINNEAPOLIS, Aug. 8, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced its participation in two upcoming conferences.

Wedbush Securities PacGrow Life Sciences Conference
Date:  Tuesday, August 14, 2012
Time:  3:40 pm ET
Location:  New York, NY
David Kaysen, President and CEO, will present the Company's strategy and recent corporate developments.

Attendance at the conference is by invitation only.  A live audio webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast may access it at  http://wsw.com/webcast/wedbush21/upi/, or through Uroplasty's website at www.uroplasty.com. An archived replay of the presentation will be available for 90 days.

32nd Annual Canaccord Growth Conference
Date:  Wednesday, August 15, 2012
Location:  Boston, MA
David Kaysen will meet with interested investors in a series of one-on-one meetings.

These meetings will not be webcast.

About Uroplasty, Inc.Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom is a global medical company committed to offering transformative treatment options to specialty physicians.  Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Our focus is the continued commercialization of our Urgent® PC Neuromodulation System, the only FDA-cleared system that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder and associated symptoms of urgency, frequency and urge incontinence. We also offer Macroplastique®, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.

 For Further Information:Uroplasty, Inc.

EVC Group  David Kaysen, President and CEO, or

Doug Sherk/Jenifer Kirtland (Investors), 415.568.9349 Medi Jiwani, Vice President, CFO, Treasurer

Chris Gale (Media), 646.201.5431952.426.6140  


'/>"/>
SOURCE Uroplasty, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
2. Uroplasty to Issue First Quarter of Fiscal 2013 Financial Results on July 26, 2012
3. Uroplasty To Present At The JMP Securities Healthcare Conference
4. Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
5. Uroplasty Announces Product Development and New Clinical Trial Initiatives
6. Uroplasty to Present at the 11th Annual JMP Securities Research Conference
7. PRA Participates in Landmark Alzheimers Prevention Clinical Trial
8. Misonix Participates In Cleveland Spine Review
9. NIPTE Will Participate in NIHs Therapeutics for Rare and Neglected Diseases (TRND) Program
10. ApolloMed ACO Selected To Participate In A Transformative New Initiative Sponsored by the Centers for Medicare and Medicaid Services
11. ViroPharma To Participate In The JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Mast Therapeutics, Inc. (NYSE MKT: MSTX), a biopharmaceutical ... heart failure, today announced that it intends to offer shares ... an underwritten public offering.  The offering is subject to market ... to whether or when the offering may be completed, or ...   --> --> Roth ...
(Date:2/9/2016)... 9, 2016 Hearing protection devices refer to ... transmitted to the inner ear. Hearing protection devices include ... devices are recommended for users exposed to noise levels ... to HPD that are inserted in the ear canal ... to provide more natural sound perception with the help ...
(Date:2/9/2016)... This TforG report includes the Surgical Procedures Database with ... in South Korea . To add ... written and numerical analysis on the current trends, size, ... latest reforms of the local Healthcare system are clearly ... The report helps businesses gain a unique insight into ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... 08, 2016 , ... Brenntag Specialties, Inc.(BSI) , is ... & Beverage and Dietary Supplement market segments across the western ... geographies east of the Rocky Mountains since 2012. Consistent performance in business ...
(Date:2/8/2016)... ... ... The Valentine’s Season is famous for gift giving with flowers, chocolates and other tokens of ... This year, for more than 5.6 million Americans suffering with Alzheimer’s, those store bought gifts ... them of the lives they’ve led and the people they’ve touched. , That’s ...
(Date:2/8/2016)... ... February 08, 2016 , ... If you are feeling ... handle, you are not alone. According to the Center for Disease Control and Prevention ... type 2 diabetes and certain types of cancer, some of the leading causes of ...
(Date:2/8/2016)... ... 2016 , ... The Bell Agency, a full service insurance ... their ongoing community enrichment program. The current campaign fundraises for Angels & Doves, ... being accepted at: http://www.angelsanddoves.com/donate.html . , Angels & Doves was founded in ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... networking and relationship-marketing firm, announced today that nominations will be accepted February ... (ISE®) West Awards. , Awards include the Information Security Executive® of ...
Breaking Medicine News(10 mins):